Cite
ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
MLA
Nose, Yohei, et al. “ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?” Annals of Surgical Oncology, vol. 29, no. 6, June 2022, pp. 3613–14. EBSCOhost, https://doi.org/10.1245/s10434-022-11437-z.
APA
Nose, Y., Yamashita, K., Takeoka, T., Momose, K., Saito, T., Tanaka, K., Yamamoto, K., Makino, T., Takahashi, T., Kurokawa, Y., Yamasaki, M., Shiraishi, O., Miyata, H., Yasuda, T., Yano, M., Eguchi, H., & Doki, Y. (2022). ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients? Annals of Surgical Oncology, 29(6), 3613–3614. https://doi.org/10.1245/s10434-022-11437-z
Chicago
Nose, Yohei, Kotaro Yamashita, Tomohira Takeoka, Kota Momose, Takuro Saito, Koji Tanaka, Kazuyoshi Yamamoto, et al. 2022. “ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?” Annals of Surgical Oncology 29 (6): 3613–14. doi:10.1245/s10434-022-11437-z.